Share this NATF page   
Atrial Fibrillation Action Initiative  →  Resources for Patients and Clinicians  → 

Clinician Resources

Clinician Resources

ESC 2012 AF Update

2012 focused update of the ESC Guidelines of the management of atrial fibrillation

A. John Camm (Chairperson) (UK)*, Gregory Y.H. Lip (UK), Raffaele De Caterina (Italy), Irene Savelieva (UK), Dan Atar (Norway), Stefan H. Hohnloser (Germany), Gerhard Hindricks (Germany), Paulus Kirchhof (UK)

European Heart Journal Advance Access
August 24, 2012



2011 AHA

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating 2006 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

L. Samuel Wann, Anne B. Curtis, Craig T. January, Kenneth A. Ellenbogen, James E. Lowe, N.A. Mark Estes, III, Richard L. Page, Michael D. Ezekowitz, David J. Slotwiner, Warren M. Jackman, William G. Stevenson and Cynthia M. Tracy

Circulation is published by the American Heart Association
Circulation published online Dec 20, 2010


HAS-BLED

A Novel User-Friendly Score (BAS-BLED) To Assess 1-Year Risk of Major Bleeding inPatients With Atrial Fibrillation: The Euro Heart Survey

Ron Pisters, MD; Deirdre A. Lane, PhD; Bobby Nieuwlaat, PhD; Cees B. de Vos, MD: Harry J. G. M. Crigns, MD; and Gregory Y.H. Lip, MD

Official publicaion of the American College of Chest Physicians
March 18, 2010


CHADs2VASC

Refining Clincal Risk Stratefication for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach: The Euro HEart Survey on Atrial Fibriallation

Gregory Y. H. Lip, Robby Nieuwhlatt, Deirdre A. Lane and Harry J. G. M. Crijns

Official publicaion of the American College of Chest Physicians
September 17, 2010


ROCKET AF

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation


Manesh R. Patel, M.D., Kenneth W. Mahaffey, M.D., Jyotsna Garg, M.S., Guohua Pan, Ph.D., Daniel E. Singer, M.D., Werner Hacke, M.D., Ph.D., Günter Breithardt, M.D., Jonathan L. Halperin, M.D., Graeme J. Hankey, M.D., Jonathan P. Piccini, M.D., Richard C. Becker, M.D., Christopher C. Nessel, M.D., John F. Paolini, M.D., Ph.D., Scott D. Berkowitz, M.D., Keith A.A. Fox, M.B., Ch.B., Robert M. Califf, M.D., and the ROCKET AF Steering Committee, for the ROCKET AF Investigators*

New England Journal of Medicine
September 8, 2011


ARISTOTLE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger, M.D., John H. Alexander, M.D., M.H.S., John J.V. McMurray, M.D., Renato D. Lopes, M.D., Ph.D., Elaine M. Hylek, M.D., M.P.H., Michael Hanna, M.D., Hussein R. Al-Khalidi, Ph.D., Jack Ansell, M.D., Dan Atar, M.D., Alvaro Avezum, M.D., Ph.D., M. Cecilia Bahit, M.D., Rafael Diaz, M.D., J. Donald Easton, M.D., Justin A. Ezekowitz, M.B., B.Ch., Greg Flaker, M.D.,
David Garcia, M.D., Margarida Geraldes, Ph.D., Bernard J. Gersh, M.D., Sergey Golitsyn, M.D., Ph.D., Shinya Goto, M.D., Antonio G. Hermosillo, M.D., Stefan H. Hohnloser, M.D., John Horowitz, M.D., Puneet Mohan, M.D., Ph.D., Petr Jansky, M.D., Basil S. Lewis, M.D., Jose Luis Lopez-Sendon, M.D., Prem Pais, M.D., Alexander Parkhomenko, M.D., Freek W.A. Verheugt, M.D., Ph.D., Jun Zhu, M.D., and Lars Wallentin, M.D., Ph.D., for the ARISTOTLE Committees and Investigators*

New England Journal of Medicine
August 28, 2011


RELY

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, M.D., Michael D. Ezekowitz, M.B., Ch.B., D.Phil., Salim Yusuf, F.R.C.P.C., D.Phil., John Eikelboom, M.D., Jonas Oldgren, M.D., Ph.D., Amit Parekh, M.D., Janice Pogue, M.Sc., Paul A. Reilly, Ph.D., Ellison Themeles, B.A., Jeanne Varrone, M.D., Susan Wang, Ph.D., Marco Alings, M.D., Ph.D., Denis Xavier, M.D., Jun Zhu, M.D., Rafael Diaz, M.D., Basil S. Lewis, M.D., Harald Darius, M.D., Hans-Christoph Diener, M.D., Ph.D., Campbell D. Joyner, M.D., Lars Wallentin, M.D., Ph.D., and the RE-LY Steering Committee and Investigators*

New England Journal of Medicine
September 8, 2009

About NATF

Patients

Professionals

Events


Membership

Giving to NATF

North American Thrombosis Forum
368 Boylston Street
Brookline, MA 02445

617 - 730 - 4120


NATF is a 501(c) nonprofit

Contact Us

© 2012 North American Thrombosis Forum


Web Development by MTC